Resultados de la búsqueda
Domínguez F, Uribarri A, Larrañaga-Moreira JM, Ruiz-Guerrero L, Pastor-Pueyo P, Gayán-Ordás J, Fernández-González B, Esteban-Fernández A, Barreiro M, López-Fernández S, Gutiérrez-Larraya Aguado F, Pascual-Figal D; Working Group on Myocarditis of the Spanish Society of Cardiology. Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis. Rev Esp Cardiol (2024) S1885-5857:00156-7.
García-Pavía P, Manuel García-Pinilla J, Lozano-Bahamonde A, Yun S, García-Quintana A, Gavira-Gómez JJ, Aibar-Arregui MÁ, Barge-Caballero G, Villota JN, Bernal L, Tarilonte P. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study. Rev Esp Cardiol (2024) S1885-5857:00240-8.
Link to the full text in Repisalud
Link to the full text in Repisalud
Pérez PC, Fernández-Herrero I, Jesús Broseta J, Ibarra-Márquez N, Blázquez-Bermejo Z, López-Azor JC, Gordillo CDC, Marcos MC, Bagudá JJ, Cosío MDG, García-Álvarez A, Farrero M, Delgado JF. Impact of natriuresis on worsening renal function during episodes of acute heart failure. Rev Esp Cardiol (2024) S1885-5857:00241-X
Real C, Pérez-García CN, Galán-Arriola C, García-Lunar I, García-Álvarez A. Right ventricular dysfunction: pathophysiology, experimental models, evaluation, and treatment. Rev Esp Cardiol (2024) S1885-5857:00238-X
Link to the full text in Repisalud
Link to the full text in Repisalud
Pérez-García CN, García-Lunar I. Everything flows, nothing stays.. or does it? Rev Esp Cardiol (2024) S1885-5857:00244-5
Sanchis J, Bueno H, García-Blas S, Gómez-Hospital JA, Martí D, Martínez-Sellés M, Domínguez-Pérez L, Díez-Villanueva P, Barrabés JA, Marín F, Villa A, Sanmartín M, Llibre C, Sionis A, Carol A, Valero E, Calvo E, Morales MJ, Elízaga J, Gómez I, Alfonso F, García Del Blanco B, Formiga F, Núñez E, Núñez J, Ariza-Solé A. Geriatric conditions and invasive management in frail patients with NSTEMI. A subgroup analysis of a randomized clinical trial. Rev Esp Cardiol (2024) 78:319-326
Pastor-Pérez FJ, Garrido-Bravo IP, Peñafiel-Verdú P, Fernández-Villa N, Manzano-Fernández S, Oliva-Sandoval MJ, Pérez-Martínez MT, Caro-Martínez C, Hernández-Vicente Á, Pascual-Figal DA; clinical trial REMOVE researches. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial. Rev Esp Cardiol (2024) 77:851-858
Bueno H, Seara G, Rosario Azcutia M, Jesús Rodríguez-García M, Peláez S, Agra Y, Dueñas CA, Gullón P, Aparicio Azcárraga P; Estrategia en Salud Cardiovascular del Sistema Nacional de Salud ESCAV Multidisciplinary Advisory Committee. Development and rollout of a national plan on cardiovascular health. Spain's cardiovascular health strategy (ESCAV). Rev Esp Cardiol (2024) 78:628-636
Alfonso F, Salamanca J, Núñez-Gil I, Ibáñez B, Sanchis J, Sabaté M, Velázquez M, Raposeiras-Roubín S, García-Camarero T, Antuña P, Mejía H, Carrillo X, Buera I, Martínez-Sellés M, Escudier-Villa JM, Sánchez-Prieto J, Blanco Ponce E, Cabezón G, Fernández-Golfín C, Pascual-Figal D, Cid B, Marcano A, González-Manzanares R, Jiménez-Valero S, Vázquez JM, Sanz-Sánchez J, Cecconi A, Del Val D, Abad-Santos F, Crea F. Rationale and design of the beta-blockers in tako-tsubo syndrome study: a randomized clinical trial (β-Tako). Rev Esp Cardiol (2024) 78:592-599
Saturi G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, Nardi E, Domínguez F, Ponziani A, Cabrera E, Caponetti AG, Lozano S, Massa P, Cobo-Marcos M, Accietto A, Castro-Urda V, Giovannetti A, Toquero J, Gagliardi C, Gómez-Bueno M, Rios-Tamayo R, Biagini E, Segovia J, Galiè N, García-Pavía P, Longhi S. Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis. Heart (2024) 110:40-48






